| MAA |
Report |
Core FFO per share (Q2)26) |
IN-LINE |
pred ~$2.08 vs. cons ~$2.06 |
MEDIUM |
| MAA |
Report |
Blended lease rate growth (Q2 same--store the pricing inflection) |
MISS |
pred ~+0.5% vs. cons ~+0.9% |
MEDIUM |
| MAA |
Report |
Same-Store NOI growth (Q2) |
IN-LINE |
pred ~-0.5% vs. cons ~-0.6% |
MEDIUM |
| MAA |
Guide |
FY2026 Core FFO/share guidance |
UNCHANGED |
guide ~$8.53 midpoint vs. cons ~$8.55 (FY2026) |
MEDIUM |
| MAA |
Guide |
FY2026 Same-Store revenue growth guidance |
UNCHANGED |
guide ~+0.55% midpoint vs. cons ~+0.7% (FY2026) |
MEDIUM |
| MAA |
Guide |
FY2026 Same-Store NOI growth guidance |
LOWER |
guide ~-0.7% midpoint vs. cons ~-0.4% (FY2026) |
LOW |
| MAA |
Guide |
July new-lease / new-lease growth trajectory (Q3 setup commentary) |
LOWER |
pred ~-6% new-lease vs. cons ~-5% implied (Q2/July) |
MEDIUM |
| MAA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.8% |
— |
MEDIUM |
| MAA |
Return |
5-day cumulative residual |
-2.8% (FADE) |
Core FFO prints near the telegraphed $2.06-2.08 midpoint, so the headline is a non-event; the stock has already round-tripped from $120 to $142 and drifted back to $135 into the print as a 'show-me' name. The move hinges on the new-lease inflection and a guide raise. Base case is a reaffirm (not a raise) with new-lease growth still ~-6% and blended tracking the low end, echoing 2025's mid-year stall. The out-period math is demanding — hitting the FY +1.0-1.5% blended target requires ~1.3-1.8% blends over the back three quarters — so even a modest Q2 beat forces the Street to keep 2026 estimates flat-to-lower and defers the recovery to 2027. That asymmetry drives a mild negative day-1 residual that continues to bleed over five days (fade) as sell-side notes trim second-half blend/NOI assumptions and reiterate 'prove-it' until pricing actually inflects. |
MEDIUM |